Handelsbanken Fonder’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Buy
41,100
+11,100
+37% +$85.8K ﹤0.01% 1401
2026
Q1
$191K Hold
30,000
﹤0.01% 1468
2025
Q4
$211K Buy
+30,000
New +$181K ﹤0.01% 1484
2025
Q2
Sell
-17,400
Closed -$116K 1543
2025
Q1
$116K Hold
17,400
﹤0.01% 1514
2024
Q4
$128K Buy
+17,400
New +$125K ﹤0.01% 1535

Other funds holding LFST

Handelsbanken Fonder's LFST Position: Q2 2026 in Review

Handelsbanken Fonder increased its Lifestance Health (LFST) stake by 37% in Q2 2026, buying an estimated $85.8K and bringing the position to 41,100 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

Handelsbanken Fonder first reported a position in LFST in Q4 2024 and has held it in 5 quarters since. 141 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Handelsbanken Fonder held 41,100 shares of Lifestance Health worth $440K as of Q2 2026.
  • Handelsbanken Fonder bought 11,100 Lifestance Health shares in Q2 2026, an estimated $85.8K.
  • Lifestance Health made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1401 holding.
  • Handelsbanken Fonder first reported a position in Lifestance Health in Q4 2024 and has held it in 5 quarters since.
  • 141 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.